Literature DB >> 10913503

Attention-deficit/hyperactivity disorder in adults: an overview.

S V Faraone1, J Biederman, T Spencer, T Wilens, L J Seidman, E Mick, A E Doyle.   

Abstract

To assess the validity of adult attention-deficit/hyperactivity disorder (ADHD), we reviewed clinical, family, psychopharmacologic, neurobiological, and outcome studies. We found multiple reports describing adults with clinical features highly reminiscent of the childhood ADHD. These adults, who are impulsive, inattentive, and restless, have the clinical "look and feel" of ADHD children. As with their childhood counterparts, many adults with ADHD suffer from antisocial, depressive, and anxiety disorders. They also show clinically significant impairments--histories of school failure, occupational problems, and traffic accidents. Studies of biological features show correspondences between child and adult cases of ADHD. Both show familial aggregation and a characteristic profile of neuropsychologic deficits; an emerging neuroimaging literature suggests that abnormalities in the same brain regions underlie both the child and adult forms of the disorder. Although these converging lines of evidence support the validity of ADHD in adults, follow-up studies of ADHD children have yielded ambiguous results. This ambiguity is in part due to differences in how researchers define the persistence of ADHD, a problem that suggests future research focus on how best to diagnose ADHD in adulthood.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913503     DOI: 10.1016/s0006-3223(00)00889-1

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  149 in total

Review 1.  Adult attention deficit hyperactivity disorder.

Authors:  S V Faraone; M T Tsuang
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

2.  Bupropion for adults with attention deficit hyperactivity disorder.

Authors:  Jeffery H Newcorn
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

3.  Lisdexamfetamine dimesylate (vyvanse), a prodrug stimulant for attention-deficit/hyperactivity disorder.

Authors:  David W Goodman
Journal:  P T       Date:  2010-05

4.  Pharmacotherapy for parents with attention-deficit hyperactivity disorder (ADHD): impact on maternal ADHD and parenting.

Authors:  Andrea Chronis-Tuscano; Mark A Stein
Journal:  CNS Drugs       Date:  2012-09-01       Impact factor: 5.749

5.  Pharmacotherapy of ADHD in Slovenia: realities and perspectives.

Authors:  Matej Stuhec
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-04       Impact factor: 4.785

6.  Diagnostic Profiles among Urban Adolescents with Unmet Treatment Needs: Comorbidity and Perceived Need for Treatment.

Authors:  Aaron Hogue; Sarah Dauber
Journal:  J Emot Behav Disord       Date:  2013-03-01

Review 7.  Assessment and management of attention-deficit hyperactivity disorder in adults.

Authors:  Margaret Weiss; Candice Murray
Journal:  CMAJ       Date:  2003-03-18       Impact factor: 8.262

Review 8.  Exposure to attention deficit hyperactivity disorder medications during pregnancy.

Authors:  Caitlin Humphreys; Facundo Garcia-Bournissen; Shinya Ito; Gideon Koren
Journal:  Can Fam Physician       Date:  2007-07       Impact factor: 3.275

9.  Correspondence of parent and teacher reports in medication trials.

Authors:  Stephen V Faraone; Joseph Biederman; Brenda Zimmerman
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-02       Impact factor: 4.785

Review 10.  The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder.

Authors:  Stephen V Faraone
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-02       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.